EBIT: Income before interest and taxes.
Bicycle Therapeutics PLC Sponsored ADR (BCYC) had EBIT of $-247.06M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$72.59M |
|
$-218.96M |
|
-- |
|
$72.59M |
|
$319.65M |
|
$-247.06M |
|
$28.26M |
|
$-218.81M |
|
$-218.81M |
|
$-218.96M |
|
$-218.96M |
|
$-218.96M |
|
$-218.96M |
|
|
EBIT |
$-247.06M |
$-240.64M |
|
69.28M |
|
69.28M |
|
$-3.16 |
|
$-3.16 |
|
| Balance Sheet Financials | |
$682.88M |
|
$6.02M |
|
$34.71M |
|
$717.60M |
|
$56.98M |
|
-- |
|
$50.64M |
|
$107.62M |
|
$609.98M |
|
$609.98M |
|
$609.98M |
|
69.37M |
|
| Cash Flow Statement Financials | |
$-249.68M |
|
$-2.35M |
|
$-0.13M |
|
$880.07M |
|
$628.72M |
|
$-251.35M |
|
$39.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-340.38% |
|
-340.38% |
|
-331.53% |
|
-301.45% |
|
-301.66% |
|
$-252.03M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
2.04 |
|
178.99 |
|
-35.90% |
|
-35.90% |
|
-30.51% |
|
-35.90% |
|
$8.79 |
|
$-3.64 |
|
$-3.60 |
|